nodes	percent_of_prediction	percent_of_DWPC	metapath
Amcinonide—ANXA1—Prostaglandin Synthesis and Regulation—HPGD—thyroid cancer	0.082	0.146	CbGpPWpGaD
Amcinonide—ANXA1—neck—thyroid cancer	0.053	0.208	CbGeAlD
Amcinonide—ANXA1—saliva-secreting gland—thyroid cancer	0.0414	0.162	CbGeAlD
Amcinonide—Dermatitis acneiform—Vandetanib—thyroid cancer	0.0405	0.221	CcSEcCtD
Amcinonide—ANXA1—trachea—thyroid cancer	0.0319	0.125	CbGeAlD
Amcinonide—ANXA1—thyroid gland—thyroid cancer	0.0253	0.0988	CbGeAlD
Amcinonide—ANXA1—head—thyroid cancer	0.0224	0.0877	CbGeAlD
Amcinonide—Folliculitis—Vandetanib—thyroid cancer	0.022	0.12	CcSEcCtD
Amcinonide—NR3C1—Regulation of Androgen receptor activity—TRIM24—thyroid cancer	0.0217	0.0386	CbGpPWpGaD
Amcinonide—NR3C1—neck—thyroid cancer	0.0184	0.0721	CbGeAlD
Amcinonide—NR3C1—Nuclear Receptors—THRB—thyroid cancer	0.0182	0.0325	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CITED1—thyroid cancer	0.0182	0.0324	CbGpPWpGaD
Amcinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—NKX2-1—thyroid cancer	0.017	0.0303	CbGpPWpGaD
Amcinonide—ANXA1—lymph node—thyroid cancer	0.0157	0.0614	CbGeAlD
Amcinonide—ANXA1—Spinal Cord Injury—LGALS3—thyroid cancer	0.0156	0.0278	CbGpPWpGaD
Amcinonide—Folliculitis—Sorafenib—thyroid cancer	0.0149	0.0811	CcSEcCtD
Amcinonide—ANXA1—Prostaglandin Synthesis and Regulation—PTGS2—thyroid cancer	0.0147	0.0262	CbGpPWpGaD
Amcinonide—NR3C1—Nuclear Receptor transcription pathway—THRB—thyroid cancer	0.0144	0.0257	CbGpPWpGaD
Amcinonide—NR3C1—saliva-secreting gland—thyroid cancer	0.0144	0.0562	CbGeAlD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—TPR—thyroid cancer	0.0129	0.023	CbGpPWpGaD
Amcinonide—NR3C1—Endoderm Differentiation—NKX2-1—thyroid cancer	0.012	0.0214	CbGpPWpGaD
Amcinonide—NR3C1—Transcription factor regulation in adipogenesis—RXRA—thyroid cancer	0.012	0.0214	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—CALCB—thyroid cancer	0.0119	0.0211	CbGpPWpGaD
Amcinonide—Secondary infection—Epirubicin—thyroid cancer	0.0117	0.0641	CcSEcCtD
Amcinonide—NR3C1—trachea—thyroid cancer	0.0111	0.0434	CbGeAlD
Amcinonide—Secondary infection—Doxorubicin—thyroid cancer	0.0109	0.0593	CcSEcCtD
Amcinonide—ANXA1—Spinal Cord Injury—CDK1—thyroid cancer	0.0107	0.019	CbGpPWpGaD
Amcinonide—NR3C1—thyroid gland—thyroid cancer	0.00877	0.0343	CbGeAlD
Amcinonide—ANXA1—Peptide ligand-binding receptors—SST—thyroid cancer	0.00837	0.0149	CbGpPWpGaD
Amcinonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—thyroid cancer	0.0083	0.0148	CbGpPWpGaD
Amcinonide—Leukoderma—Epirubicin—thyroid cancer	0.00812	0.0443	CcSEcCtD
Amcinonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—RXRA—thyroid cancer	0.00792	0.0141	CbGpPWpGaD
Amcinonide—NR3C1—head—thyroid cancer	0.00778	0.0304	CbGeAlD
Amcinonide—NR3C1—Nuclear Receptors—RXRA—thyroid cancer	0.00775	0.0138	CbGpPWpGaD
Amcinonide—NR3C1—Transcription factor regulation in adipogenesis—PPARG—thyroid cancer	0.00758	0.0135	CbGpPWpGaD
Amcinonide—Leukoderma—Doxorubicin—thyroid cancer	0.00751	0.041	CcSEcCtD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—TSHR—thyroid cancer	0.00722	0.0129	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (i) signalling events—SST—thyroid cancer	0.00706	0.0126	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.00674	0.012	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CALCB—thyroid cancer	0.00671	0.012	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—CDK1—thyroid cancer	0.0066	0.0118	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—RET—thyroid cancer	0.00634	0.0113	CbGpPWpGaD
Amcinonide—NR3C1—Nuclear Receptor transcription pathway—RXRA—thyroid cancer	0.00612	0.0109	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CALCB—thyroid cancer	0.00609	0.0109	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of Androgen receptor activity—RXRA—thyroid cancer	0.00594	0.0106	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—THRB—thyroid cancer	0.00589	0.0105	CbGpPWpGaD
Amcinonide—NR3C1—Circadian Clock—RXRA—thyroid cancer	0.00576	0.0103	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—SST—thyroid cancer	0.00561	0.01	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—TSHR—thyroid cancer	0.0055	0.00979	CbGpPWpGaD
Amcinonide—Folliculitis—Epirubicin—thyroid cancer	0.00549	0.03	CcSEcCtD
Amcinonide—NR3C1—lymph node—thyroid cancer	0.00545	0.0213	CbGeAlD
Amcinonide—NR3C1—AP-1 transcription factor network—CDK1—thyroid cancer	0.00512	0.00912	CbGpPWpGaD
Amcinonide—Folliculitis—Doxorubicin—thyroid cancer	0.00508	0.0277	CcSEcCtD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—BRAF—thyroid cancer	0.005	0.00891	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—PTGS2—thyroid cancer	0.00492	0.00876	CbGpPWpGaD
Amcinonide—Infection—Vandetanib—thyroid cancer	0.00491	0.0268	CcSEcCtD
Amcinonide—NR3C1—Nuclear Receptors—PPARG—thyroid cancer	0.00489	0.00872	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—PTCH1—thyroid cancer	0.00467	0.00832	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—CCND1—thyroid cancer	0.00445	0.00792	CbGpPWpGaD
Amcinonide—Rash pustular—Epirubicin—thyroid cancer	0.00433	0.0236	CcSEcCtD
Amcinonide—NR3C1—Circadian Clock—HIF1A—thyroid cancer	0.00428	0.00763	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—SST—thyroid cancer	0.00427	0.00761	CbGpPWpGaD
Amcinonide—Stinging—Epirubicin—thyroid cancer	0.00426	0.0232	CcSEcCtD
Amcinonide—Pain—Vandetanib—thyroid cancer	0.00422	0.0231	CcSEcCtD
Amcinonide—ANXA1—GPCR ligand binding—CALCA—thyroid cancer	0.00411	0.00733	CbGpPWpGaD
Amcinonide—Rash pustular—Doxorubicin—thyroid cancer	0.004	0.0219	CcSEcCtD
Amcinonide—Stinging—Doxorubicin—thyroid cancer	0.00394	0.0215	CcSEcCtD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—PRKAR1A—thyroid cancer	0.00392	0.00698	CbGpPWpGaD
Amcinonide—NR3C1—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.00387	0.00689	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—CCND1—thyroid cancer	0.00365	0.0065	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CALCB—thyroid cancer	0.0036	0.00641	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—HIF1A—thyroid cancer	0.00353	0.00629	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—PTEN—thyroid cancer	0.00352	0.00628	CbGpPWpGaD
Amcinonide—Pruritus—Vandetanib—thyroid cancer	0.00349	0.0191	CcSEcCtD
Amcinonide—NR3C1—Generic Transcription Pathway—TRIM33—thyroid cancer	0.00344	0.00614	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TRIM33—thyroid cancer	0.00341	0.00608	CbGpPWpGaD
Amcinonide—Dermatitis contact—Epirubicin—thyroid cancer	0.00341	0.0186	CcSEcCtD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	0.00335	0.00596	CbGpPWpGaD
Amcinonide—Infection—Sorafenib—thyroid cancer	0.00331	0.0181	CcSEcCtD
Amcinonide—Dermatitis contact—Doxorubicin—thyroid cancer	0.00315	0.0172	CcSEcCtD
Amcinonide—Dermatitis—Vandetanib—thyroid cancer	0.00311	0.017	CcSEcCtD
Amcinonide—ANXA1—GPCR downstream signaling—TSHR—thyroid cancer	0.00311	0.00553	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—SST—thyroid cancer	0.0031	0.00552	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	0.00302	0.00539	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—TP53—thyroid cancer	0.00293	0.00522	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	0.00292	0.0052	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—RXRA—thyroid cancer	0.0029	0.00516	CbGpPWpGaD
Amcinonide—Pain—Sorafenib—thyroid cancer	0.00285	0.0155	CcSEcCtD
Amcinonide—ANXA1—Signaling by GPCR—TSHR—thyroid cancer	0.00282	0.00502	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PRKAR1A—thyroid cancer	0.00277	0.00494	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—KRAS—thyroid cancer	0.0027	0.00482	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—THRB—thyroid cancer	0.00249	0.00444	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—SST—thyroid cancer	0.00241	0.0043	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—TP53—thyroid cancer	0.0024	0.00428	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PTCH1—thyroid cancer	0.0024	0.00427	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—thyroid cancer	0.00237	0.00422	CbGpPWpGaD
Amcinonide—Pruritus—Sorafenib—thyroid cancer	0.00236	0.0129	CcSEcCtD
Amcinonide—ANXA1—GPCR downstream signaling—CALCA—thyroid cancer	0.00232	0.00414	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TCF7L1—thyroid cancer	0.00228	0.00405	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	0.00224	0.00399	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—SST—thyroid cancer	0.00219	0.00391	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—HIF1A—thyroid cancer	0.00215	0.00383	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—CCND1—thyroid cancer	0.00213	0.0038	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CALCA—thyroid cancer	0.00211	0.00376	CbGpPWpGaD
Amcinonide—Dermatitis—Sorafenib—thyroid cancer	0.0021	0.0115	CcSEcCtD
Amcinonide—NR3C1—AP-1 transcription factor network—PTEN—thyroid cancer	0.00206	0.00367	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—thyroid cancer	0.00204	0.00363	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—AKT1—thyroid cancer	0.00203	0.00362	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	0.00199	0.00355	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CDK1—thyroid cancer	0.00191	0.0034	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—HIF1A—thyroid cancer	0.00186	0.00331	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—PPARG—thyroid cancer	0.00183	0.00326	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—thyroid cancer	0.00173	0.00309	CbGpPWpGaD
Amcinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—thyroid cancer	0.00172	0.00307	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	0.00168	0.003	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TSHR—thyroid cancer	0.00167	0.00297	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—TRIM33—thyroid cancer	0.00166	0.00295	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PRKAR1A—thyroid cancer	0.00164	0.00292	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—MEN1—thyroid cancer	0.00158	0.00282	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MEN1—thyroid cancer	0.00157	0.00279	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PTCH1—thyroid cancer	0.00142	0.00252	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—TP53—thyroid cancer	0.00141	0.0025	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—SST—thyroid cancer	0.0013	0.00231	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CALCA—thyroid cancer	0.00125	0.00222	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—thyroid cancer	0.00124	0.00221	CbGpPWpGaD
Amcinonide—Infection—Epirubicin—thyroid cancer	0.00122	0.00668	CcSEcCtD
Amcinonide—NR3C1—Gene Expression—THRB—thyroid cancer	0.0012	0.00214	CbGpPWpGaD
Amcinonide—Infection—Doxorubicin—thyroid cancer	0.00113	0.00618	CcSEcCtD
Amcinonide—ANXA1—Signaling Pathways—CDK1—thyroid cancer	0.00113	0.00201	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—RXRA—thyroid cancer	0.00106	0.00188	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—thyroid cancer	0.00106	0.00188	CbGpPWpGaD
Amcinonide—Pain—Epirubicin—thyroid cancer	0.00105	0.00575	CcSEcCtD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—thyroid cancer	0.00105	0.00186	CbGpPWpGaD
Amcinonide—Pain—Doxorubicin—thyroid cancer	0.000974	0.00532	CcSEcCtD
Amcinonide—ANXA1—Signaling Pathways—NRG1—thyroid cancer	0.000906	0.00161	CbGpPWpGaD
Amcinonide—Pruritus—Epirubicin—thyroid cancer	0.000871	0.00475	CcSEcCtD
Amcinonide—ANXA1—Signaling Pathways—TERT—thyroid cancer	0.000814	0.00145	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—TPR—thyroid cancer	0.00081	0.00144	CbGpPWpGaD
Amcinonide—Pruritus—Doxorubicin—thyroid cancer	0.000806	0.0044	CcSEcCtD
Amcinonide—ANXA1—Signaling Pathways—HIF1A—thyroid cancer	0.000778	0.00139	CbGpPWpGaD
Amcinonide—Dermatitis—Epirubicin—thyroid cancer	0.000775	0.00423	CcSEcCtD
Amcinonide—NR3C1—Gene Expression—MEN1—thyroid cancer	0.000761	0.00136	CbGpPWpGaD
Amcinonide—Dermatitis—Doxorubicin—thyroid cancer	0.000717	0.00392	CcSEcCtD
Amcinonide—ANXA1—Signaling by GPCR—NRAS—thyroid cancer	0.000685	0.00122	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—PPARG—thyroid cancer	0.000668	0.00119	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—BRAF—thyroid cancer	0.000644	0.00115	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—KRAS—thyroid cancer	0.00059	0.00105	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—RXRA—thyroid cancer	0.000509	0.000907	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—HRAS—thyroid cancer	0.000501	0.000893	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—AKT1—thyroid cancer	0.000488	0.000869	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CCND1—thyroid cancer	0.00047	0.000838	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PTEN—thyroid cancer	0.000454	0.000809	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—AKT1—thyroid cancer	0.000443	0.000789	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NRAS—thyroid cancer	0.000405	0.000721	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—KRAS—thyroid cancer	0.000348	0.000621	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—PPARG—thyroid cancer	0.000322	0.000573	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TP53—thyroid cancer	0.00031	0.000552	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HRAS—thyroid cancer	0.000296	0.000528	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—AKT1—thyroid cancer	0.000262	0.000466	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—AKT1—thyroid cancer	0.000127	0.000227	CbGpPWpGaD
